Clear Street LLC raised its holdings in Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC – Free Report) by 6,942.6% in the second quarter, Holdings Channel reports. The fund owned 8,592 shares of the company’s stock after acquiring an additional 8,470 shares during the period. Clear Street LLC’s holdings in Bellevue Life Sciences Acquisition were worth $92,000 at the end of the most recent quarter.
Several other large investors also recently modified their holdings of the business. Condor Capital Management bought a new position in shares of Bellevue Life Sciences Acquisition during the 4th quarter valued at about $121,000. K2 Principal Fund L.P. acquired a new stake in Bellevue Life Sciences Acquisition during the 1st quarter worth approximately $358,000. Warberg Asset Management LLC lifted its stake in Bellevue Life Sciences Acquisition by 47.1% in the second quarter. Warberg Asset Management LLC now owns 39,781 shares of the company’s stock valued at $429,000 after buying an additional 12,741 shares in the last quarter. Finally, Berkley W R Corp acquired a new position in shares of Bellevue Life Sciences Acquisition in the first quarter valued at approximately $3,440,000. 55.30% of the stock is currently owned by institutional investors.
Bellevue Life Sciences Acquisition Price Performance
Shares of BLAC stock opened at $10.89 on Thursday. Bellevue Life Sciences Acquisition Corp. has a 12-month low of $10.39 and a 12-month high of $11.60. The firm has a fifty day moving average of $10.84 and a 200-day moving average of $10.77.
Bellevue Life Sciences Acquisition Company Profile
Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington.
Featured Articles
- Five stocks we like better than Bellevue Life Sciences Acquisition
- Where to Find Earnings Call Transcripts
- 3 Stocks to Neutralize Market Volatility and Build Wealth
- What Investors Need to Know About Upcoming IPOs
- How Much Can You Make in Stocks in One Month?
- Canada Bond Market Holiday: How to Invest and Trade
- This Is the Top Large-Cap Stock Insiders Are Buying
Want to see what other hedge funds are holding BLAC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC – Free Report).
Receive News & Ratings for Bellevue Life Sciences Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellevue Life Sciences Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
